News ArchivesRead News
Implanted eye cells eased Parkinson’s
Thursday December 22, 2005
December 19, 2005(Reuters Health) - A handful of people with Parkinson’s disease showed marked improvement after surgeons implanted in their brains chemical-producing cells taken from the eye of a dead donor, researchers said last week.
Cells from the inner, or pigment, layer of the eye’s retina make levodopa, which Parkinson’s patients commonly take in pill form to replace lost production of the neurotransmitter dopamine.
Dopamine allows the brain to control the body’s movements.
For most patients, levodopa pills lose their effectiveness within five years, and larger and larger doses are needed to curb the involuntary movements and shaking symptomatic of the disease.
Many people on the drug develop involuntary writhing or dance-like movements.
The retina cells were cultivated and implanted in the brains of six patients with advanced Parkinson’s, researcher Natividad Stover of the University of Alabama said.
One year later, the patients scored 48 percent higher on tests of movement and coordination, and the improvement was sustained after two years, Stover wrote in the journal Archives of Neurology.
’’The implants were well tolerated," the report said. Improvement was also observed in daily living and quality of life.
Parkinson’s is a degenerative disease in which key brain cells that produce dopamine die off. Symptoms start with tremors and rigidity, and patients can end up paralyzed. The cause of the disease, which attacks 2 percent of men and 1.3 percent of women, is unknown, and there is no cure.
Some scientists have viewed implanting fetal stem cells into the brains of Parkinson’s patients as a promising avenue to restore dopamine production. But preliminary human trials were disappointing, and animal experiments have yielded mixed results.
Other treatments showing promise include deep brain stimulation with implanted electrodes, drugs that promote brain cell growth, and gene therapy.
The researchers said a larger study has been started to test the efficacy and safety of retina cell implants.
Recent NewsMay 15 - Study offers answers on life expectancy for people with Parkinson's disease, Lewy body dementia
May 5 - Parkinson's in a dish: Researchers reproduce brain oscillations
May 5 - ‘Hunger Hormone’ Could Help Treat Parkinson’s Disease
May 3 - Antibiotic doxycycline may offer hope for treatment of Parkinson's disease
May 1 - Impulse Control Disorders in Parkinson's Disease: Building Physician, Patient Awareness
Apr 28 - Does Parkinson’s disease begin in the gut?
Apr 28 - New empathy-creating digital device could be revolutionary for caregivers
Apr 24 - Treating Depression With Deep Brain Stimulation Works—Most of the Time
Apr 24 - Parkinson’s disease shows links to depression
Apr 21 - TOLEDO Trial: Apomorphine Infusions Reduce 'Off' Time in Parkinson's Disease
Apr 21 - New drug provides long-awaited breakthrough for Parkinson's psychosis
Apr 12 - Obstructive Sleep Apnea Affects Cognition in Parkinson's Disease
Apr 11 - Seattle boxing gym giving hope to Parkinson's patients
Apr 10 - A new rhythm
Apr 10 - Brain cells reprogrammed to make dopamine, with goal of Parkinson's therapy
Apr 6 - FDA allows marketing of first direct-to-consumer tests that provide genetic risk information for certain conditions
Apr 5 - Combatting the isolation of young onset Parkinson's disease
Apr 1 - The Kid is Alright
Mar 30 - Hepatitis Tied to Parkinson's Risk
Mar 28 - Elon Musk's new company said to see brain-computer link